Neuropsychiatric symptoms and lifelong mental activities in cerebral amyloid angiopathy - a cross-sectional study
- PMID: 39232823
- PMCID: PMC11375846
- DOI: 10.1186/s13195-024-01519-3
Neuropsychiatric symptoms and lifelong mental activities in cerebral amyloid angiopathy - a cross-sectional study
Abstract
Background: While several studies in cerebral amyloid angiopathy (CAA) focus on cognitive function, data on neuropsychiatric symptoms (NPS) and lifelong mental activities in these patients are scarce. Since NPS are associated with functional impairment, faster cognitive decline and faster progression to death, replication studies in more diverse settings and samples are warranted.
Methods: We prospectively recruited n = 69 CAA patients and n = 18 cognitively normal controls (NC). The number and severity of NPS were assessed using the Alzheimer's Disease (AD) Assessment Scale's (ADAS) noncognitive subscale. We applied different regression models exploring associations between NPS number or severity and group status (CAA vs. NC), CAA severity assessed with magnetic resonance imaging (MRI) or cognitive function (Mini-Mental State Examination (MMSE), ADAS cognitive subscale), adjusting for age, sex, years of education, arterial hypertension, AD pathology, and apolipoprotein E status. Mediation analyses were performed to test indirect effects of lifelong mental activities on CAA severity and NPS.
Results: Patients with CAA had 4.86 times (95% CI 2.20-10.73) more NPS and 3.56 units (95% CI 1.94-5.19) higher expected NPS severity than NC. Higher total CAA severity on MRI predicted 1.14 times (95% CI 1.01.-1.27) more NPS and 0.57 units (95% CI 0.19-0.95) higher expected NPS severity. More severe white matter hyperintensities were associated with 1.21 times more NPS (95% CI 1.05-1.39) and 0.63 units (95% CI 0.19-1.08) more severe NPS. NPS number (MMSE mean difference - 1.15, 95% CI -1.67 to -0.63; ADAS cognitive mean difference 1.91, 95% CI 1.26-2.56) and severity (MMSE - 0.55, 95% CI -0.80 to -0.30; ADAS cognitive mean difference 0.89, 95% CI 0.57-1.21) predicted lower cognitive function. Greater lifelong mental activities partially mediated the relationship between CAA severity and NPS (indirect effect 0.05, 95% CI 0.0007-0.13), and greater lifelong mental activities led to less pronounced CAA severity and thus to less NPS (indirect effect - 0.08, 95% CI -0.22 to -0.002).
Discussion: This study suggests that NPS are common in CAA, and that this relationship may be driven by CAA severity. Furthermore, NPS seem to be tied to lower cognitive function. However, lifelong mental activities might mitigate the impact of NPS in CAA.
Keywords: Alzheimer’s disease; Cerebral amyloid angiopathy; Depression; Lifelong mental activities; Magnetic resonance imaging; Neuropsychiatric symptoms; White matter hyperintensities.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
The authors declare no conflict of interest.
Figures

Similar articles
-
Cerebral Amyloid Angiopathy Is Associated With Emotional Dysregulation, Impulse Dyscontrol, and Apathy.J Am Heart Assoc. 2021 Nov 16;10(22):e022089. doi: 10.1161/JAHA.121.022089. Epub 2021 Nov 10. J Am Heart Assoc. 2021. PMID: 34755541 Free PMC article.
-
Cerebral Amyloid Angiopathy Is Associated With Executive Dysfunction and Mild Cognitive Impairment.Stroke. 2016 Aug;47(8):2010-6. doi: 10.1161/STROKEAHA.116.012999. Epub 2016 Jun 23. Stroke. 2016. PMID: 27338926
-
Mediators of cognitive impairment in cerebral amyloid angiopathy.Int J Stroke. 2023 Jan;18(1):78-84. doi: 10.1177/17474930221099352. Epub 2022 May 19. Int J Stroke. 2023. PMID: 35473418
-
Cerebral amyloid angiopathy-related cognitive impairment: The search for a specific neuropsychological pattern.Rev Neurol (Paris). 2017 Nov;173(9):562-565. doi: 10.1016/j.neurol.2017.09.006. Epub 2017 Oct 6. Rev Neurol (Paris). 2017. PMID: 28993004 Review.
-
Prevalence of Clinical and Neuroimaging Markers in Cerebral Amyloid Angiopathy: A Systematic Review and Meta-Analysis.Stroke. 2022 Jun;53(6):1944-1953. doi: 10.1161/STROKEAHA.121.035836. Epub 2022 Mar 10. Stroke. 2022. PMID: 35264008
Cited by
-
Associations of inferior frontal sulcal hyperintensities on brain MRI with cerebral small vessel disease, cognitive function, and depression symptoms.Sci Rep. 2025 Jan 23;15(1):2999. doi: 10.1038/s41598-025-87493-8. Sci Rep. 2025. PMID: 39849098 Free PMC article.
-
Leveraging multiomic approaches to elucidate mechanisms of heterogeneity in Alzheimer's disease: Neuropsychiatric symptoms, co-pathologies, and sex differences.Alzheimers Dement. 2025 Aug;21(8):e70549. doi: 10.1002/alz.70549. Alzheimers Dement. 2025. PMID: 40823789 Free PMC article. Review.
References
-
- Charidimou A, Boulouis G, Frosch MP, Baron J-C, Pasi M, Albucher JF, Banerjee G, Barbato C, Bonneville F, Brandner S, Calviere L, Caparros F, Casolla B, Cordonnier C, Delisle M-B, Deramecourt V, Dichgans M, Gokcal E, Herms J, Hernandez-Guillamon M, Jäger HR, Jaunmuktane Z, Linn J, Martinez-Ramirez S, MartinezSaez E, Mawrin C, Montaner J, Moulin S, Olivot J-M, Piazza F, Puy L, Raposo N, Rodrigues MA, Roeber S, Romero JR, Samarasekera N, Schneider JA, Schreiber S, Schreiber F, Schwall C, Smith C, Szalardy L, Varlet P, Viguier A, Wardlaw JM, Warren A, Wollenweber FA, Zedde M, van Buchem MA, Gurol ME, Viswanathan A, Salman RA-S, Smith EE, Werring DJ, Greenberg SM. The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study. Lancet Neurol. 2022;21(8):714–25. 10.1016/S1474-4422(22)00208-3 - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical